PRECISION BIOSCIENCES INC License Agreements
8 Contracts & Agreements
- License Agreement, effective as of August 15, 2023 by and between Precision BioSciences, Inc. and Imugene (USA) Inc (Filed With SEC on August 21, 2023)
- First Amendment to Development and License Agreement between Eli Lilly and Company and Precision BioSciences, Inc., dated August 9, 2021 (Filed With SEC on November 10, 2021)
- Development and License Agreement between Eli Lilly and Company and Precision BioSciences, Inc., dated November 19, 2020 (Filed With SEC on March 18, 2021)
- Amendment No. 6, dated October 16, 2020, to Development and Commercial License Agreement by and between Les Laboratoires Servier, Institut de Recherches Internationales Servier... (Filed With SEC on November 10, 2020)
- Amendment No. 5, dated October 23, 2019, to Development and Commercial License Agreement by and between Les Laboratoires Servier and Precision BioSciences, Inc., dated February... (Filed With SEC on November 12, 2019)
- Development and Commercial License Agreement by and between Les Laboratoires Servier and the Registrant, dated February 24, 2016, as amended (Filed With SEC on March 13, 2019)
- Development and Commercial License Agreement by and between Les Laboratoires Servier and the Registrant, dated February 24, 2016, as amended (Filed With SEC on March 1, 2019)
- License Agreement by and between Duke University and the Registrant, dated April 17, 2006, as amended (Filed With SEC on March 1, 2019)
